2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 00:27, 12 December 2023
, 12 December 2023→Potential Benefits
| Line 118: | Line 118: | ||
While direct transportation into the cell and dephosphorylation to NR can coexists, studies in mice indicate that orally ingested NMN is predominantly converted to NR in the intestinal tissue before absorption, challenging the view of NMN as a direct precursor to NAD+{{pmid|37463842}}. | While direct transportation into the cell and dephosphorylation to NR can coexists, studies in mice indicate that orally ingested NMN is predominantly converted to NR in the intestinal tissue before absorption, challenging the view of NMN as a direct precursor to NAD+{{pmid|37463842}}. | ||
==Potential Benefits== | ==Potential Longevity Benefits== | ||
NMN supplementation has been associated with several potential benefits, primarily due to its role as a precursor to NAD+, a crucial coenzyme involved in various cellular processes. Here are some potential benefits based on preliminary research: | NMN supplementation has been associated with several potential benefits, primarily due to its role as a precursor to NAD+, a crucial coenzyme involved in various cellular processes. Here are some potential benefits based on preliminary research: | ||
{| class="wikitable" style="width:90%; background-color:white; vertical-align:top; margin:auto;" | {| class="wikitable" style="width:90%; background-color:white; vertical-align:top; margin:auto;" | ||